Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The good news is that GM generated about $3.1 billion in profit in the quarter. The bad news is that this is the only good news.
The European Space Agency has contracted Elon Musk’s SpaceX to launch navigation satellites next year, The Wall Street Journal reported.
The National Basketball Association is on a full-court press to secure its next round of broadcast rights.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Choice Hotels International went public on Tuesday with a nearly $8 billion hostile bid to acquire Wyndham Hotels and Resorts.
Health insurance costs are expected to surge by as much as 6.5% next year, according to a recent survey from consulting firm Mercer.
People are buying EVs, just not at the hyper-pace most automakers were hoping would be here by now, The Wall Street Journal reported.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
On Thursday, Ikea announced that cooling inflation means it can finally return to its customer-friendly ways.
Chinese raw materials companies are cozying up with battery makers in Morocco and South Korea as a way of bypassing US restrictions.
ExxonMobil announced it will purchase Pioneer Natural Resources for just under $60 billion, marking the largest oil-and-gas deal in decades.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.